Mantovani, G., Maccio, A., Madeddu, C., Serpe, R., Massa, E., Dessi, M., Panzone, F., and Contu, P
Dispose of the syringe and the solution in a proper sharps container and start over
AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza (saxagliptin)
Acknowledgments We would like to acknowledge the reviewers for their helpful comments on this study
Early findings indicate that MOTS-c may play a role in helping the body adapt to changing energy demands, potentially contributing to improved metabolic stability and performance
Mounjaro is the newest advancement in GLP-1 therapies, combining GLP-1 and GIP receptor agonists for increased weight loss effects all while minimizing side effects